María Angeles Botí

Dr. María Angeles Botí

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2022 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
ACAnna Campabadal
Anna Campabadal
JOJavier Oltra
Javier Oltra
CJCarme Junque
Carme Junque
NGNúria Guillen
Núria Guillen
MBMaría Angeles Botí
María Angeles Botí
BSBarbara Segura
Barbara Segura
Objective: This research aims to study structural brain changes in patients with persistent olfactory dysfunctions after coronavirus disease 2019 (COVID‐19).Methods: COVID‐19 patients were evaluated using T1‐weighted and diffusion tensor imaging (DTI) on a 3T MRI scanner, 9.94 ± 3.83 months after COVID‐19 diagnosis. Gray matter (GM) voxel‐based morphometry was performed using FSL‐VBM. Voxelwise statistical analysis of the fractional anisotropy, mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity was carried out with the tract‐based spatial statistics in the olfactory system. The smell identification test (UPSIT) was used to classify patients as normal olfaction or olfactory dysfunction groups. Intergroup comparisons between GM and DTI measures were computed, as well as correlations with the UPSIT scores.Results: Forty‐eight COVID‐19 patients were included in the study. Twenty‐three were classified as olfactory dysfunction, and 25 as normal olfaction. The olfactory dysfunction group had lower GM volume in a cluster involving the left amygdala, insular cortex, parahippocampal gyrus, frontal superior and inferior orbital gyri, gyrus rectus, olfactory cortex, caudate, and putamen. This group also showed higher MD values in the genu of the corpus callosum, the orbitofrontal area, the anterior thalamic radiation, and the forceps minor; and higher RD values in the anterior corona radiata, the genu of the corpus callosum, and uncinate fasciculus compared with the normal olfaction group. The UPSIT scores for the whole sample were negatively associated with both MD and RD values (p‐value ≤0.05 FWE‐corrected).Interpretation: There is decreased GM volume and increased MD in olfactory‐related regions explaining prolonged olfactory deficits in post‐acute COVID‐19 patients.

10 January 2025 in European Psychiatry
Verified
Journal Article
Open access
PDF file
APAndres Pemau
Andres Pemau
ATAlejandro de la Torre-Luque
Alejandro de la Torre-Luque
CMCarolina Marín Martín
Carolina Marín Martín
MMMarina Díaz Marsá
Marina Díaz Marsá
JAJorge Andreo-Jover
Jorge Andreo-Jover
VSVíctor Pérez Sola
Víctor Pérez Sola
Background: One of the most relevant risk factors for suicide is the presence of previous attempts. The symptomatic profile of people who reattempt suicide deserves attention. Network analysis is a promising tool to study this field. Objective: To analyze the symptomatic network of patients who have attempted suicide recently and compare networks of people with several attempts and people with just one at baseline. Methods: 1043 adult participants from the Spanish cohort “SURVIVE” were part of this study. Participants were classified into two groups: single attempt group (n = 390) and reattempt group (n = 653). Different network analyses were carried out to study the relationships between suicidal ideation, behavior, psychiatric symptoms, diagnoses, childhood trauma, and impulsivity. A general network and one for each subgroup were estimated. Results: People with several suicide attempts at baseline scored significantly higher across all clinical scales. The symptomatic networks were equivalent in both groups of patients (p > .05). Although there were no overall differences between the networks, some nodes were more relevant according to group belonging. Conclusions: People with a history of previous attempts have greater psychiatric symptom severity but the relationships between risk factors show the same structure when compared with the single attempt group. All risk factors deserve attention regardless of the number of attempts, but assessments can be adjusted to better monitor the occurrence of reattempts.

20 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LCLaura Comendador
Laura Comendador
DVDiego J Palao Vidal
Diego J Palao Vidal
Antoni SanzAntoni Sanz
Antoni Sanz
JAJorge Andreo
Jorge Andreo
EBEnrique Baca-Garcia
Enrique Baca-Garcia
VSVíctor Pérez Sola
Víctor Pérez Sola
Background/Objectives: Psychological pain—also termed psychache or mental pain—has been suggested to constitute a relevant factor in the emergence of suicidal behaviour. Despite conceptual advances, empirical research on interventions specifically designed to alleviate psychological pain in individuals who have attempted suicide remains scarce. The present scoping review maps existing psychological and pharmacological interventions targeting psychological pain, identifies their core components, delineates gaps for future research, and proposes a therapeutic intervention protocol. Methods: Literature was searched through PubMed, PsycInfo, and ClinicalTrials.gov (until October 2025) using combinations of the terms suicide, psychache, psychological pain, intervention, treatment, therapy, pharmacological treatment, and psychotherapy. Both randomised controlled trials, non-randomised controlled trials, and literature reviews were included. Results: Evidence indicates that few interventions explicitly target psychological pain. Most suicide-specific therapies indirectly address components of psychological pain—such as unbearable affect, loss of meaning, and social disconnection. Narrative-based, emotion regulation, and acceptance-based therapies appear promising. Emerging pharmacological approaches may relieve psychological pain; however, further evidence is required. Conclusions: Integrating psychological pain as a therapeutic focus—through narrative, tolerance-building, and relational strategies—may enhance post-attempt interventions. Future trials should systematically measure psychological pain and test its role as a mediator of suicidal outcomes.

25 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
LCLaura Comendador
Laura Comendador
DVDiego J Palao Vidal
Diego J Palao Vidal
Antoni SanzAntoni Sanz
Antoni Sanz
JAJorge Andreo
Jorge Andreo
EBEnrique Baca-Garcia
Enrique Baca-Garcia
VSVíctor Pérez Sola
Víctor Pérez Sola
Background/Objectives: Psychological pain—also termed psychache or mental pain—has been suggested to constitute a relevant factor in the emergence of suicidal behaviour. Despite conceptual advances, empirical research on interventions specifically designed to alleviate psychological pain in individuals who have attempted suicide remains scarce. The present scoping review maps existing psychological and pharmacological interventions targeting psychological pain, identifies their core components, delineates gaps for future research, and proposes a therapeutic intervention protocol. Methods: Literature was searched through PubMed, PsycInfo, and ClinicalTrials.gov (until October 2025) using combinations of the terms suicide, psychache, psychological pain, intervention, treatment, therapy, pharmacological treatment, and psychotherapy. Both randomised controlled trials, non-randomised controlled trials, and systematic reviews were included. Results: Evidence indicates that few interventions explicitly target psychological pain. Most suicide-specific therapies indirectly address components of psychological pain—such as unbearable affect, loss of meaning, and social disconnection. Narrative-based, emotion regulation, and acceptance-based therapies appear promising. Emerging pharmacological approaches may relieve mental pain, however, further evidence is required. Conclusion: Integrating psychological pain as a therapeutic focus—through narrative, tolerance-building, and relational strategies—may enhance post-attempt interventions. Future trials should systematically measure psychological pain and test its role as a mediator of suicidal outcomes.